Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Biosimilars Suits Likely To Remain Copious Even As Zarxio 'Patent Dance' Battle Seems Over

This article was originally published in The Pink Sheet Daily

Executive Summary

Federal Circuit denies Amgen and Sandoz petitions to rehear case; separate ongoing litigation – or even a Supreme Court appeal – could provide opening for further challenges.



Related Companies